门控SPECT心肌灌注显像评估心脏再同步化治疗中的心室内同步性:心肌病类型是否影响结果?
结果显示LVNC组基线相位标准差(PSD)显著更高(89.5°±14.2° vs 65.2°±23.3°和69.7°±21.7°,p=0.007),CRT后PSD降至63.7°±20.5°(p=0.028),6个月时89%患者为应答者且LVNC组100%应答。
要点
- LVNC心肌病患者基线心室内同步性较其他类型心肌病更差,PSD更高。
- CRT后所有组心室内不同步均改善,LVNC组改善最显著。
- 门控SPECT相位分析可用于评估CRT应答。
核心结论
- CRT对非缺血性心肌病合并心肌致密化不全患者的心室内同步性有显著改善作用。
- 门控SPECT心肌灌注显像的相位分析是评估CRT应答的有价值工具。
研究设计与样本
- 分为三组:组1为非缺血性心肌病伴LVNC(11例),组2为缺血性心肌病(28例),组3为非缺血性心肌病(53例)。
- 所有患者于CRT植入前和术后6±1个月行静息99mTc-MIBI门控SPECT心肌灌注显像,包括相位分析评估心室内不同步。
- 生活质量采用明尼苏达心力衰竭生活质量问卷(MLHFQ)测量。
主要发现
- 基线时LVNC组PSD为89.5°±14.2°,显著高于组2的65.2°±23.3°和组3的69.7°±21.7°(p=0.007)。
- 缺血性患者平均SRS为14.9,显著高于非缺血性组1的8.7和组2的9(p<0.0001)。
- CRT后所有组生活质量显著改善,非缺血性患者(伴或不伴LVNC)6个月时LVEF增加和容积缩小更明显。
- LVNC组PSD从基线89.5°±14.2°降至CRT后63.7°±20.5°(p=0.028)。
- CRT后6个月89%患者为应答者:LVNC组11例(100%)、缺血性组25例(86%)、非缺血性组47例(89%)。
关键数值与推荐
- 心室内不同步以相位标准差(PSD)评估,基线LVNC组PSD为89.5°±14.2°。
- CRT应答定义为6个月时临床和功能变量改善,总体应答率89%。
- LVNC组随访期间无患者发生不良事件。
临床怎么用
- 对拟行CRT的心肌病患者,可用门控SPECT心肌灌注显像相位分析评估基线心室内不同步。
- LVNC患者基线不同步更明显,CRT后同步性改善和应答率较高,提示此类患者可从CRT获益。
- 相位分析可作为CRT术后应答评估的影像学工具。
局限性
- LVNC组样本量仅11例,结果需更大样本验证。
- 随访时间为6±1个月,缺乏长期预后数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze the evolution post-cardiac resynchronization therapy (CRT) in left ventricular non-compaction (LVNC) cardiomyopathy (CM) patients compared to other types of CM, according to clinical and functional variables, by using gated-SPECT myocardial perfusion imaging (MPI). METHODS: Ninety-three patients (60 ± 11 years, 28% women) referred for pre-CRT assessment were studied and divided into three groups: 1 (non-ischemic CM with LVNC, 11 patients), 2 (ischemic CM, 28 patients), and 3 (non-ischemic CM, 53 patients). All were studied by a 99mTc-MIBI gated-SPECT MPI at rest pre-CRT implantation and 6 ± 1 months after, including intraventricular dyssynchrony assessment by phase analysis. Quality of life was measured by the Minnesota Living with Heart Failure Questionnaire (MLHFQ). RESULTS: No differences in sex, atherosclerotic risk factors other than smoking habit, and MLHFQ results were found among groups. LVNC CM patients were younger, with greater QRS width and lower left ventricular ejection fraction (LVEF) at baseline, but the differences were not significant. No significant differences were found at baseline regarding ventricular function, although end-systolic volume was slightly higher in LVNC CM patients. Mean SRS was significantly higher (p < 0.0001) in ischemic patients (14.9) versus non-ischemic ones (8.7 in group 1 and 9 in group 2). At baseline, LVNC CM patients were significantly more dyssynchronous: Their phase standard deviation (PSD) was higher (89.5° ± 14.2°) versus groups 2 (65.2° ± 23.3°) and 3 (69.7° ± 21.7°), p = 0.007. Although the quality of life significantly improved in all groups, non-ischemic patients (with or without LVNC) showed a higher LVEF increase and volumes reduction at 6 months post-CRT. Dyssynchrony reduced post-CRT in all groups. Nevertheless, those more dyssynchronous at baseline (LVNC CM) exhibited the most significant intraventricular synchronism improvement: PSD was reduced from 89.5° ± 14.2° at baseline to 63.7° ± 20.5° post-CRT (p = 0.028). Six months post-CRT, 89% of patients were responders: 11 (100%) of those with LVNC CM, 25 (86%) of those with ischemic CM, and 47 (89%) of patients with non-ischemic CM. No patient with LVNC CM had adverse events during the follow-up. CONCLUSION: CRT contributes to a marked improvement in non-ischemic CM patients with non-compaction myocardium. Phase analysis in gated-SPECT MPI is a valuable tool to assess the response to CRT.
引用
- Peix A, Padrón K, Cabrera LO, et al. Intraventricular synchronism assessment by gated-SPECT myocardial perfusion imaging in cardiac resynchronization therapy. Does cardiomyopathy type influence results? EJNMMI Res. 2020. PMID: 33079263. doi:10.1186/s13550-020-00703-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。